Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-74.10	21.54	83.14
Graham Fair Price	41.43	1.00	0.70
PEG	-59.68	-0.02	0.05
Price/Book	-12.50	0.14	0.16
Price/Cash Flow	99.54	-15.45	-3381.39
Prices/Earnings	56.25	-1.83	-4.18
Price/Sales	-56.25	0.18	0.41
Price/FCF	99.54	-15.45	-3381.39
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.17	0.17
Operating Margin	0.00	< 0.005	< 0.005
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	-0.02	-100.00
ROIC	< 0.005	< 0.005	-97.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.03	-0.07	-51.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.98	-1.00	2.09
EPS QOQ	0.92	-0.99	8.50
FCF QOQ	-1.00	-190.45	-18936.07
Revenue QOQ	-0.38	1.00	164.66
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	30.71	15.36	-50.00
Days Sales Outstanding (DSO)	129.24	70.60	-45.38
Inventory Turnover	2.93	5.86	100.00
Debt/Capitalization	0.41	0.42	1.98
Quick Ratio	0.90	0.98	8.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.54	1.54	< 0.005
Cash	0.15	0.15	1.91
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	< 0.005	-0.01	-19045.30
Revenue	0.58	1.17	100.01
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.17	1.17	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	66.05	17.68	-73.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating